DXS InternationalAQSE:DXSP Current Ratio is 1.01 as of Apr. 2025, which is 32% below its 10-year median of 1.49. The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, DXS International ranks worse than 72.98% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. DXS International's current ratio for the quarter that ended in Apr. 2025 was 1.01.
DXS International has a current ratio of 1.01. It generally indicates good short-term financial strength.
The historical rank and industry rank for DXS International's Current Ratio or its related term are showing as below:
AQSE:DXSP'
s Current Ratio Range Over the Past 10 Years
Min: 1.01 Med: 1.49 Max: 1.73
Current: 1.01
During the past 11 years, DXS International's highest Current Ratio was 1.73. The lowest was 1.01. And the median was 1.49.
AQSE:DXSP's Current Ratio is ranked worse than 72.98% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.48
vs AQSE:DXSP: 1.01
DXS International (AQSE:DXSP) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
DXS International Current Ratio Related Terms
DXS International Current Ratio Historical Data
* Premium members only.
The historical data trend for DXS International's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:DXSP vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, DXS International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's Current Ratio distribution charts can be found below:
* The bar in red indicates where DXS International's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International (AQSE:DXSP) has a Current Ratio of 1.01 as of Apr. 2025. This is 32% below median its historical median of 1.49. Over the past decade, DXS International's Current Ratio has ranged from 1.01 to 1.73. According to the industry distribution chart, DXS International ranks #497 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 73%.
Is DXS International's Current Ratio too high?
DXS International's current Current Ratio of 1.01 is 32% below median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 1.73. The Healthcare Providers & Services industry median Current Ratio is 1.48. DXS International's value of 1.01 is 31.8% below this industry median. Based on the distribution chart, DXS International ranks #497 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does DXS International's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #497 out of 681 companies for Current Ratio. This places DXS International in the lower half of its industry. The industry median Current Ratio is 1.48. DXS International's value of 1.01 is 31.8% below this benchmark. Historically, DXS International's own Current Ratio has ranged from 1.01 to 1.73 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 1.48, DXS International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DXS International's current Current Ratio of 1.01 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current Current Ratio is 1.01, which is 32% below median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current Current Ratio is 1.01, which is 32% below median its 10-year median of 1.49 and 31.8% below the Healthcare Providers & Services industry median of 1.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Current Ratio is 1.01 as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:DXSP has been successfully added to your 